Post-Finasteride Syndrome or Pre-Existing Vulnerability? Rethinking Patient Selection
May 2025
in “
Journal of Cosmetic Dermatology
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → 
Studysummary This research emphasizes the importance of integrating pre-treatment psychological assessments for individuals considering finasteride, highlighting that these assessments could help identify those prone to nocebo responses, potentially reducing adverse symptom development more related to cognitive vulnerabilities than to the drug itself.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The article discusses post-finasteride syndrome (PFS), a condition with persistent symptoms reported by some after stopping finasteride, a drug for androgenetic alopecia. It suggests that PFS may often be linked to pre-existing psychological vulnerabilities rather than the drug itself, highlighting the role of nocebo responses where negative expectations cause symptoms. The author emphasizes the importance of addressing psychological factors and misinformation when prescribing finasteride. A proposed solution is a pre-treatment psychological screening tool to identify individuals at risk of adverse outcomes, which could improve patient outcomes and reduce treatment discontinuation. The article calls for further research to develop standardized screening tools and integrate psychological assessments into finasteride prescribing practices.
